By: Agwanda Saye
Med Aditus is partnering with the Kisumu County Government and the Great Lakes University of Kisumu (GLUK) to establish a $40 million pharmaceutical manufacturing plant. This facility will produce subsidized, high-quality drugs for the Great Lakes Region and beyond.
Located next to the Great Lakes University, the manufacturing facility aims for an annual production capacity of two billion tablets/capsules. It will target both non-communicable diseases, including cardiovascular conditions, diabetes, and cancer, and infectious diseases such as HIV, malaria, and tuberculosis, as well as drugs addressing neglected tropical diseases.
Kisumu Governor Prof. Anyang’ Nyong’o reviewed the construction progress with Dr. Dhiren R. Thakker, Ph.D., CEO of Med Aditus, alongside Prof. Bob Blouin, CEO of Med Aditus Foundation. They were accompanied by Prof. Khama Rogo, Head of the World Bank Group’s Health Africa Initiative.
The plant’s establishment is largely financed through Afreximbank’s intervention under the bank’s Africa Health Security Investment Plan. This initiative is aimed at strengthening the continent’s health product manufacturing capacity and is expected to create hundreds of job opportunities for the local community.
The meeting was attended by Chief Officer for Health Dr. Ojwang’ Lusi, Chief Officer for Lands Victor Kanyaura, Director of Medical Services Dr. Don Ogolla, among other County Government officers.
